Longitudinal cognitive biomarkers predicting symptom onset in presymptomatic frontotemporal dementia

J Neurol. 2018 Jun;265(6):1381-1392. doi: 10.1007/s00415-018-8850-7. Epub 2018 Apr 7.

Abstract

Introduction: We performed 4-year follow-up neuropsychological assessment to investigate cognitive decline and the prognostic abilities from presymptomatic to symptomatic familial frontotemporal dementia (FTD).

Methods: Presymptomatic MAPT (n = 15) and GRN mutation carriers (n = 31), and healthy controls (n = 39) underwent neuropsychological assessment every 2 years. Eight mutation carriers (5 MAPT, 3 GRN) became symptomatic. We investigated cognitive decline with multilevel regression modeling; the prognostic performance was assessed with ROC analyses and stepwise logistic regression.

Results: MAPT converters declined on language, attention, executive function, social cognition, and memory, and GRN converters declined on attention and executive function (p < 0.05). Cognitive decline in ScreeLing phonology (p = 0.046) and letter fluency (p = 0.046) were predictive for conversion to non-fluent variant PPA, and decline on categorical fluency (p = 0.025) for an underlying MAPT mutation.

Discussion: Using longitudinal neuropsychological assessment, we detected a mutation-specific pattern of cognitive decline, potentially suggesting prognostic value of neuropsychological trajectories in conversion to symptomatic FTD.

Keywords: Biomarkers; Cognition; Familial; Frontotemporal dementia; Longitudinal; Neuropsychological assessment; Presymptomatic.

MeSH terms

  • Adult
  • Cognitive Dysfunction / diagnosis
  • Cognitive Dysfunction / genetics
  • Female
  • Follow-Up Studies
  • Frontotemporal Dementia / diagnosis*
  • Frontotemporal Dementia / genetics
  • Frontotemporal Dementia / psychology*
  • Genetic Predisposition to Disease
  • Heterozygote
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Multilevel Analysis
  • Mutation
  • Neuropsychological Tests
  • Prodromal Symptoms
  • Prognosis
  • Progranulins
  • ROC Curve
  • Regression Analysis
  • tau Proteins / genetics

Substances

  • GRN protein, human
  • Intercellular Signaling Peptides and Proteins
  • MAPT protein, human
  • Progranulins
  • tau Proteins